Trial Profile

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Dec 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tetanus vaccine Tianjin CanSino Biotechnology (Primary)
Indications Tetanus
Focus Adverse reactions; Pharmacodynamics; Registrational
Sponsors Tianjin CanSino Biotechnology

Most Recent Events

02 Dec 2024 Status changed from recruiting to completed.
29 Mar 2024 Status changed from not yet recruiting to recruiting.
11 Mar 2024 Planned initiation date changed from 1 Dec 2023 to 1 Apr 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com